CAMBRIDGE, United Kingdom

Robert Curtis

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Global Life Sciences Solutions USA LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Curtis. Retrieved from https://idiyas.com/inventor/robert-curtis-r75k7k3d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert Curtis

Introduction

Robert Curtis is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cell therapy, holding a total of 3 patents. His work is recognized for its impact on the manufacturing processes within the life sciences sector.

Latest Patents

Among his latest patents are the "Cell Therapy Manufacturing Receptacle" and the "Cell Therapy Manufacturing Apparatus." These innovations are designed to enhance the efficiency and effectiveness of cell therapy production, showcasing his commitment to advancing medical technology.

Career Highlights

Robert Curtis is currently employed at Global Life Sciences Solutions USA LLC. His role at this esteemed company allows him to leverage his expertise in developing innovative solutions that address complex challenges in the life sciences industry.

Collaborations

Throughout his career, Robert has collaborated with talented individuals such as Andreu Fontova Sosa and Nicolas Petitfourg. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Robert Curtis exemplifies the spirit of innovation in the life sciences field. His contributions through patents and collaborations continue to shape the future of cell therapy manufacturing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…